Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 87 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Income Statement [Abstract]      
Revenues       $ 733
Operating Expenses:      
Research and Development 967 1,005 16,469
General and Administrative 565 53 2,343
Total operating expenses (1,532) 1,058 18,812
Loss from operations (1,532) (1,058) (18,079)
Interest income       40
Other income       9
Interest expense       (2)
Fair value of warrant liabilities in excess of proceeds from financing (946)    (946)
Change in fair value of derivative liabilities 2,106    6,271
Total other income, net 1,160    5,372
Net loss (400) (1,058) (12,707)
Comprehensive loss:      
Net loss (372) (1,058) (12,707)
Unrealized loss on marketable securities (1,451)      
Total comprehensive loss $ (1,823) $ (1,058) $ (12,707)
Net loss per common share:      
Basic loss per share $ 0.00 $ (0.02)  
Weighted average common shares outstanding, basic 324,471 57,255  
Diluted loss per share $ 0.00 $ (0.02)  
Weighted average common shares outstanding, diluted 324,471 57,255